Coverage
-
October 14, 2015
The Affordable Care Act fully exempts orphan drugs from mandatory discounts under the 340B program for certain health care providers, a D.C. federal judge said Wednesday in an important victory for trade group Pharmaceutical Research and Manufacturers of America.
7 other articles on this case.
View all »